Skip to content
10-Q

Quarterly Report

Clearside Biomedical, Inc. CLSDQ

0000950170-25-105812

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 78.51M sh
Shares Diluted Q2 2025 · Jun 30, 2025 77.84M sh
Shares Diluted Q2 2025 · Jun 30, 2025 77.39M sh
Shares Diluted Q2 2025 · Jun 30, 2024 74.73M sh
Shares Diluted Q2 2025 · Jun 30, 2024 72.29M sh
Capex Q2 2025 · Jun 30, 2025 $9K
Capex Q2 2025 · Jun 30, 2024 $480K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$10.56M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$13.53M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $9.38M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $20.02M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$48.73M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$45.91M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$38.86M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$28.29M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$21.81M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$15.91M
Current Liabilities Q2 2025 · Jun 30, 2025 $3.05M
Current Liabilities Q2 2025 · Dec 31, 2024 $4.79M
Total Liabilities Q2 2025 · Jun 30, 2025 $64.07M
Total Liabilities Q2 2025 · Dec 31, 2024 $63.98M
Current Assets Q2 2025 · Jun 30, 2025 $11.79M
Current Assets Q2 2025 · Dec 31, 2024 $21.27M
Total Assets Q2 2025 · Jun 30, 2025 $15.33M
Total Assets Q2 2025 · Dec 31, 2024 $25.13M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.06
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.16
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.10
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.27
Eps Basic Q2 2025 · Jun 30, 2025 −$0.06
Eps Basic Q2 2025 · Jun 30, 2025 −$0.16
Eps Basic Q2 2025 · Jun 30, 2024 −$0.10
Eps Basic Q2 2025 · Jun 30, 2024 −$0.27
Sga Expense Q2 2025 · Jun 30, 2025 $2.48M
Sga Expense Q2 2025 · Jun 30, 2025 $5.3M
Sga Expense Q2 2025 · Jun 30, 2024 $3.08M
Sga Expense Q2 2025 · Jun 30, 2024 $5.9M
Rd Expense Q2 2025 · Jun 30, 2025 $1.58M
Rd Expense Q2 2025 · Jun 30, 2025 $6.05M
Rd Expense Q2 2025 · Jun 30, 2024 $4.6M
Rd Expense Q2 2025 · Jun 30, 2024 $10.22M
Net Income Q2 2025 · Jun 30, 2025 −$4.5M
Net Income Q2 2025 · Jun 30, 2025 −$12.72M
Net Income Q2 2025 · Mar 31, 2025 −$8.22M
Net Income Q2 2025 · Jun 30, 2024 −$7.59M
Net Income Q2 2025 · Jun 30, 2024 −$19.36M
Net Income Q2 2025 · Mar 31, 2024 −$11.76M
Operating Income Q2 2025 · Jun 30, 2025 −$3.57M
Operating Income Q2 2025 · Jun 30, 2025 −$8.77M
Operating Income Q2 2025 · Jun 30, 2024 −$7.59M
Operating Income Q2 2025 · Jun 30, 2024 −$15.8M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $0
Cost Of Revenue Q2 2025 · Jun 30, 2025 $248K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $0
Cost Of Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2025 $492K
Revenue Q2 2025 · Jun 30, 2025 $2.82M
Revenue Q2 2025 · Jun 30, 2024 $90K
Revenue Q2 2025 · Jun 30, 2024 $320K